Daniel Roling, MD
Dermatology · Bryn Mawr, PANPI 1285659425
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by LEO Pharma Inc. at 35.3% of the total. 2025 is the largest year on record at $1,870, 4.1 times the $451 reported in 2019.
Across 79 payments — averaging $53.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$2K
- Novartis$619
- LEO Pharma AS$450
- Sanofi$372
- Dr.reddy's Laboratories,inc.$325
- AbbVie$307
- plus $682 from 13 others
What the payments were for
- Consulting fees$2,50359%
- Speaking & faculty fees$3508%
- Food & beverage$1,40233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 5 | $1,500 |
| Novartis | 25 | $619 |
| LEO Pharma AS | 1 | $450 |
| Sanofi | 3 | $372 |
| Dr.reddy's Laboratories,inc. | 1 | $325 |
| AbbVie | 19 | $307 |
| Cepheid | 1 | $303 |
| Pfizer | 5 | $105 |
| Strata Skin Sciences, Inc. | 7 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Incyte Corporation | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Amgen | 1 | $18 |
| Biofrontera Inc. | 1 | $13 |
| EPI Health, LLC | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,255 in reported general payments places this provider in the 65th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $75,513 |
| Clobetasol Propionate | 110 | $7,321 |
| Doxycycline Hyclate | 24 | $2,988 |
| Fluorouracil | 38 | $2,644 |
| Triamcinolone Acetonide | 159 | $2,351 |
| Tacrolimus | 15 | $2,121 |
| ValacyclovirValacyclovir Hcl | 42 | $1,297 |
| Ketoconazole | 53 | $1,195 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 62 | $1,183 |
| Hydrocortisone | 63 | $551 |
| Fluocinonide | 18 | $456 |
| Metronidazole | 14 | $364 |
| Nystatin | 16 | $183 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bryn Mawr
- Edward RyanBryn Mawr$159K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.